Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Peripherin-2 (PRPH2; HGNC:9942) encodes a tetraspanin critical for photoreceptor outer segment morphogenesis. Heterozygous PRPH2 variants typically cause autosomal dominant pattern dystrophy, cone-rod dystrophy or retinitis pigmentosa, while bi-allelic loss-of-function leads to early-onset Leber congenital amaurosis within the broader category of inherited retinal dystrophy (MONDO:0019118). Given extensive allelic heterogeneity, both dominant-negative and haploinsufficiency mechanisms have been described.
Genetic evidence includes a multi-generation family with fundus flavimaculatus, central areolar chorioretinal dystrophy and macular pattern dystrophy in heterozygotes and an LCA-like early-onset retinal dystrophy in one homozygote for c.715C>T (p.Gln239Ter) ([PMID:31618092]). Independent reports of five homozygous probands from two kindreds (three children, two adults) with infantile nystagmus and non-recordable ERGs confirm recessive PRPH2 LCA phenotypes; all available heterozygous parents exhibited macular changes ([PMID:26061163]).
Larger cohorts reinforce the dominant association: 40 Japanese patients from 30 families carried 17 distinct pathogenic or likely pathogenic variants with p.Arg142Trp and p.Val200Glu relatively frequent ([PMID:34828423]). In a Spanish series of 220 patients from 103 families, 56 variants were identified, 64% missense clustering in the D2 loop domain, and founder alleles p.Leu41Pro and p.Pro221_Cys222del were ascertained by haplotype analysis ([PMID:38474159]).
The variant spectrum exceeds 245 unique alleles: missense, frameshift, nonsense, splice-site, deep-intronic and complex indels. Recurrent hotspots include p.Arg172Trp, p.Gly167Ser, p.Cys213Tyr, and the splice-site founder c.828+3A>T, which segregates in 19 families and modifies phenotype severity depending on trans-haplotype ([PMID:26842753]).
Functional studies demonstrate that wild-type PRPH2 rescues photoreceptor dysplasia in rds/rds mice ([PMID:1385966]), while targeted D2-loop mutagenesis uncouples fusogenic activity from biosynthesis and disc targeting ([PMID:15252042]) and defines Cys165–Asn182 as essential for homo-/hetero-oligomerization with ROM1 ([PMID:15779916]). The R172W knock-in model recapitulates late-onset cone degeneration and shows only transient rescue with supplementation, supporting both dominant-negative and haploinsufficiency mechanisms ([PMID:18055786]).
Collectively, definitive genetic and experimental data spanning over 700 index patients from hundreds of families establish PRPH2 as a definitive cause of inherited retinal dystrophy. Comprehensive PRPH2 sequencing is warranted in patients with pattern dystrophy, cone-rod dystrophy or non-recordable ERGs for precise diagnosis, prognostic counseling and eligibility for gene-based therapies.
Key Take-home: PRPH2 exhibits a definitive autosomal dominant association with inherited retinal dystrophy, with dose-sensitive outcomes ranging from pattern dystrophy in heterozygotes to early-onset LCA in homozygotes.
Gene–Disease AssociationDefinitiveOver 700 index patients from hundreds of unrelated families; consistent segregation across multigenerational pedigrees and concordant functional studies. Genetic EvidenceStrong56 distinct pathogenic or likely pathogenic variants in 133 families (220 patients) and segregation in >100 families; includes both dominant and recessive presentations. Functional EvidenceModerateMultiple in vivo rescue and transgenic models confirm haploinsufficiency and dominant-negative mechanisms; D2-loop assays define oligomerization and fusogenic defects. |